TransMedics Group's loss under GAAP for 9 months of 2020 amounted to $22.437 million, which is 7.9% lower compared to $24.37 million in the previous year. Revenue increased 2.7% to $18.012 million, against $17.547 million a year earlier.
TransMedics Group's loss under GAAP for 9 months of 2020 amounted to $22.437 million, which is 7.9% lower compared to $24.37 million in the previous year. Revenue increased 2.7% to $18.012 million, against $17.547 million a year earlier. 
English (US) 